[PharmaEssentia] Announcement on the Completion of Registration for Capital Reduction via Cancellation of Restricted Employee Shares

1. Date approved by competent authority for capital reduction: May 25, 115 2. Date of completion of capital change registration: May 25, 115 3. Impact on financial statements (including differences in paid-in capital, shares outstanding, and book value per share): Before Reduction: Paid-in Capital 3,799,093,700 NTD, Outstanding Shares 371,637,704, Book Value per Share 92.71 NTD After Reduction: Paid-in Capital 3,799,013,700 NTD, Outstanding Shares 371,629,704, Book Value per Share 92.71 NTD Note: Book value per share is calculated based on the financial statements reviewed by accountants for Q1 of 115. 4. Planned share exchange schedule: N/A 5. Expected listed common shares after reduction: N/A 6. Ratio of expected listed common shares to total issued common shares after reduction: N/A 7. Countermeasures for low liquidity: N/A 8. Other important items: The number of restricted employee shares canceled in this instance is 8,000 shares.